Is Celyad Oncology S.A. (CYAD) a Buy, Sell, or Hold?
NASDAQ : CYAD
Celyad Oncology S.A.
$0.47 USD
-$0.07 (-12.96%)
- Volume
- 49K
- Average Volume
- 18.58K
- Market Capitalization
- $14.24M
- P/E Ratio
- -2.94
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.07
- Year Low
- $0.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.79
CYAD vs. The Competition
| Properties | CYAD | ATON | AXLA | GLS |
|---|---|---|---|---|
| Market Cap | $14.24M | $666.63K | $12.5M | $11.63M |
| Shares Outstanding | $30.29M | $2.28M | $2.73M | $73.33M |
| P/E Ratio | -2.94 | -0.03 | -3.61 | -0.2 |
| EPS | -0.14 | -7.1 | -1.27 | -0.79 |
| Day Low | 0.47 | 0.2422 | 0.36 | 0.145 |
| Day High | 0.528 | 0.3094 | 4.58 | 0.1622 |
| Year Low | 0.15 | 0.176 | 0.36 | 0.012 |
| Year High | 3.07 | 13.8 | 4.58 | 5.67 |
| Average Price 50 | 0.662867 | 0.35684 | 0 | 0.1832484 |
| Average Price 200 | 1.0653743 | 3.13577 | 0 | 0.6126981 |
| Volume | 48998 | 13.97M | 6782 | 185.17K |
| Average Volume | - | - | - | - |